A silent opponent: Staphylococcus aureus and its impact on wrestlers

Abstract

Community acquired methicillin resistant Staphylococcus aureus infections have surged dramatically over the past decade. Athletes in contact sports, especially wrestlers, represent a unique subset of young, healthy individuals who are at heightened risk for transmitting methicillin resistant Staphylococcus aureus. The sport of wrestling has seen a significant increase in participation, particularly among adolescents, underscoring its growing popularity and the urgent need to address this issue. Unfortunately, the rates of community acquired methicillin resistant Staphylococcus aureus have followed a similar upward trend. Treatment options for community acquired methicillin resistant Staphylococcus aureus vary, ranging from topical or systemic antibiotics to more invasive interventions like incision, drainage, and intralesional injections. Preventive measures are also essential and include avoiding shared equipment, meticulous mat and gear cleaning, and eliminating bacterial colonization. While existing research supports the effectiveness of decolonization strategies in hospital settings, there is a pressing need to adapt and implement these approaches within the wrestling community. Current prevention methods, such as mat cleaning and skin checks before competitions, are insufficient on their own. By adopting more comprehensive decolonization protocols tailored to the wrestling environment, we can better protect athletes and reduce the incidence of community acquired methicillin resistant Staphylococcus aureus skin infections.

Keywords

transmission - carriage - prevention - athletes - infection

Publication History

Received: 25 August 2024

Accepted after revision: 14 January 2025

Article published online:
25 February 2025

• References

• 1 Thomas T, Moore A, Nath S, Kearns G. Research Letter: Staphylococcus aureus infections in wrestlers: a cause for concern. Arch Derm Res 2024; 317: 24
• 2 Centers for Disease Control and Prevention. 2019 https://www.cdc.gov/antimicrobial-resistance/data-research/threats/index.html
• 3 World Health Organization. 2015 https://www.who.int/publications/i/item/9789241509763
• 4 World Health Organization. 2020 https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
• 5 Burnham JP, Kollef MH. Treatment of severe skin and soft tissue infections: A review. Curr Opin Infect Dis 2018; 31: 113-119
• 6 Fridkin SK, Hageman JC, Morrison M. et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352: 1436-1444
• 7 David MZ, Daum RS. Update on epidemiology and treatment of MRSA infections in children. Curr Pediatr Rep 2013; 1: 170-181
• 8 Kourtis AP, Hatfield K, Baggs J. et al. Vital signs: Epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections – United States. MMWR Morb Mortal Wkly Rep 2019; 68: 214-219
• 9 Kaye KS, Patel DA, Stephens JM, Khachatryan A, Patel A, Johnson K. Rising United States hospital admissions for acute bacterial skin and skin structure infections: Recent trends and economic impact. PLoS One 2015; 10: 0143276
• 10 Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008; 168: 1585-1591
• 11 Suaya JA, Mera RM, Cassidy A. et al. Incidence and cost of hospitalizations associated with Staphylococcus aureus skin and soft tissue infections in the United States from 2001 through 2009. BMC Infect Dis 2014; 14: 296
• 12 Champion AE, Goodwin TA, Brolinson PG. et al. Prevalence and characterization of methicillin-resistant Staphylococcus aureus isolates from healthy university student athletes. Annals of Clinical Microbiology and Antimicrobials. 2014; 13: 33
• 13 Schad T. 2024 https://www.usatoday.com/story/sports/olympics/2024/03/25/girls-womens-wrestling-participation-high-school-colleges/73037830007/#:~:text=According%20to%20statistics%20compiled%20by,for%20which%20data%20is%20available
• 14 Braun T, Kahanov L. Community-associated methicillin-resistant Staphylococcus aureus infection rates and management among student-athletes. Med Sci Sports Exerc 2018; 50: 1802-1809
• 15 Jiménez-Truque N, Saye EJ, Soper NR. MRSA colonization and infection in college athletes: A prospective cohort study. Infect Control Hosp Epidemiol 2021; 42: 542-550
• 16 Hudson BG, Bentz ML, Li T. The epidemiology of methicillin-resistant Staphylococcus aureus among collegiate athletes: A systematic review. J Athl Train 2020; 55: 793-801
• 17 Dienst WL, Dightman L, Dworkin MS, Thompson RK, Howe WB. Pinning down skin infections: Diagnosis, treatment, and prevention in wrestlers. Phys Sportsmed 1997; 25: 45-56
• 18 Herzog MM, Fraser MA, Register-Mihalik JK, Kerr ZY. Epidemiology of skin infections in menʼs wrestling: Analysis of 2009-2010 through 2013-2014 NCAA surveillance data. J Athl Train 2017; 52: 457-463
• 19 Yard EE, Collins CL, Dick RW, Comstock RD. An epidemiologic comparison of high school and college wrestling injuries. Am J Sports Med 2008; 36: 57-64
• 20 Wilson EK, Deweber K, Berry JW, Wilckens JH. Cutaneous infections in wrestlers. Sports Health 2013; 5: 423-437
• 21 Jiménez-Truque N, Saye EJ, Soper N. et al. Longitudinal assessment of colonization with Staphylococcus aureus in healthy collegiate athletes. J Pediatric Infect Dis Soc 2016; 5: 105-113
• 22 Jiménez-Truque N, Saye EJ, Soper NR. et al. Association between contact sports and colonization with Staphylococcus aureus in a prospective cohort of collegiate athletes. Sports Med (Auckland, NZ) 2017; 47: 1011-1019
• 23 Martykanova DS, Davletova NC, Zemlenuhin IA. et al. Skin microbiota in contact sports athletes and selection of antiseptics for professional hygiene. Biomed Res Int 2019; 2019: 9843781
• 24 Leyden JJ, McGinley KJ, Nordstrom KM. et al. Skin microflora. J Investig Dermatol 1987; 88: 65-72
• 25 Chmielowiec-Korzeniowska A, Tymczyna L, Wlazło Ł, Nowakowicz-Dębek B, Trawińska B. Carriage state in healthy adult population and phenotypic and genotypic properties of isolated strains. Postepy Dermatol Alergol 2020; 37: 184-189
• 26 Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: A meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 36: 131-139
• 27 Turner NA, Sharma-Kuinkel BK, Maskarinec SA. et al. Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research. Nat Rev Microbiol 2019; 17: 203-218
• 28 Vestergaard M, Frees D, Ingmer H. Antibiotic resistance and the MRSA problem. Microbiol Spectr 2019; 7: 1-23
• 29 Troeman DPR, Kluytmans JAJW. From nares to wound: Exploring the mechanisms for staphylococcal surgical site infections, implications for infection prevention. Antimicrob Steward Healthc Epidemiol 2023; 3: 130
• 30 Maurice Bilung L, Tahar AS, Kira R, Mohd Rozali AA, Apun K. High occurrence of Staphylococcus aureus isolated from fitness equipment in selected gymnasiums. J Environ Public Health 2018; 2018: 4592830
• 31 Stanforth B, Krause A, Starkey C, Ryan TJ. Prevalence of community-associated methicillin-resistant Staphylococcus aureus in high school wrestling environments. J Environ Health 2010; 72: 12-16
• 32 Brancaccio M, Mennitti C, Laneri S. et al. Methicillin-resistant Staphylococcus aureus: Risk for general infection and endocarditis among athletes. Antibiotics (Basel) 2020; 332
• 33 Albureikan MOI, Alotaibi LMA. Antibacterial activity of chloroxylenol and thymol against pathogenic bacteria isolated from under long nails. Eur Rev Med Pharmacol Sci 2023; 27: 3922-3930
• 34 Shoaib M, Aqib AI, Muzammil I. et al. MRSA compendium of epidemiology, transmission, pathophysiology, treatment, and prevention within one health framework. Front Microbiol 2022; 13: 1067284
• 35 Linz MS, Mattappallil A, Finkel D, Parker D. Clinical impact of Staphylococcus aureus skin and soft tissue infections. Antibiotics (Basel) 2023; 12: 557
• 36 Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations and management. Clin Microbiol Rev 2015; 28: 603-661
• 37 Miró EM, Sánchez NP. Cutaneous manifestations of infectious diseases. Atlas of Dermatology in Internal Medicine. 2011: 77-119
• 38 Newland JG, Kearns GL. Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics. Paediatr Drugs 2008; 10: 367-378
• 39 van Rijen M, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008; 2008: 006216
• 40 Stevens DL, Bisno AL, Chambers HF. et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59: 10-52
• 41 UpToDate. https://www.uptodate.com/contents/skin-abscesses-in-adults-treatment
• 42 Epocrates. https://www.epocrates.com/
• 43 Liu J, Fang Z, Yu Y. et al. Pathogens distribution and antimicrobial resistance in bloodstream infections in twenty-five neonatal intensive care units in China, 2017–2019. Antimicrob Resist Infect Control 2021; 10: 121
• 44 Moore AY, Del Rosso J, Johnson JL, Grada A. Sarecycline: A review of preclinical and clinical evidence. Clin Cosmet Investig Dermatol 2020; 13: 553-560
• 45 Andrei S, Droc G, Stefan G. FDA approved antibacterial drugs: 2018-2019. Discoveries (Craiova) 2019; 7: 102
• 46 Ford CA, Hurford IM, Cassat JE. Antivirulence strategies for the treatment of Staphylococcus aureus infections: A mini-review. Front Microbiol 2020; 11: 632706
• 47 Esposito S, Blasi F, Curtis N. et al. New antibiotics for Staphylococcus aureus infection: An update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA. Antibiotics (Basel) 2023; 12: 742
• 48 He S, Leanse LG, Feng Y. Artificial intelligence and machine learning assisted drug delivery for effective treatment of infectious diseases. Adv Drug Deliv Rev 2021; 178: 113922
• 49 Chaturvedi P, Singh AK, Singh AK, Shukla S, Agarwal L. Prevalence of mupirocin resistant Staphylococcus aureus isolates among patients admitted to a tertiary care hospital. N Am J Med Sci 2014; 6: 403-407
• 50 Labrecque S, Shah S, Fergus D, Parry MF. Mupirocin susceptibility of staphylococci 2022: Is it time for a change in MRSA decolonization protocols. Am J Infect Control 2023; 5: 725-728
• 51 Millar EV, Chen WJ, Schlett CD. et al. Frequent use of chlorhexidine-based body wash associated with a reduction in methicillin-resistant Staphylococcus aureus nasal colonization among military trainees. Antimicrob Agents Chemother 2015; 59: 943-949
• 52 Kim HY, Lee WK, Na S, Roh YH, Shin CS, Kim J. The effects of chlorhexidine gluconate bathing on health care-associated infection in intensive care units: A meta-analysis. J Crit Care 2016; 32: 126-137
• 53 Cluzet VC, Gerber JS, Metlay JP. et al. The effect of total household decolonization on clearance of colonization with methicillin-resistant Staphylococcus aureus . Infect Control Hosp Epidemiol 2016; 37: 1226-1233
• 54 Huang SS, Singh R, McKinnell JA. et al. Decolonization to reduce postdischarge infection risk among MRSA carriers. N Engl J Med 2019; 380: 638-650
• 55 U.S. Centers for Disease Control and Prevention. https://www.cdc.gov/mrsa/community/team-hc-providers/advice-for-athletes.html
• 56 Kline SE. et al. Reduction of Methicillin-Resistant Staphylococcus aureus Infections in Athletic Facilities Using a Comprehensive Cleaning Protocol. Infect Control Hosp Epidemiol 2009; 30: 1040-1045
• 57 Tosti R. et al. The Impact of Cleaning and Disinfection on Reducing Methicillin-Resistant Staphylococcus aureus (MRSA) Contamination in Athletic Equipment. J Sports Sci Med 2011; 10: 353-358
• 58 Rezapoor M, Nicholson T, Tabatabaee RM, Chen AF, Maltenfort MG, Parvizi J. Povidone-Iodine-Based Solutions for Decolonization of Nasal Staphylococcus aureus: A Randomized, Prospective, Placebo-Controlled Study. J Arthroplasty 2017; 32: 2815-2819
• 59 Phillips M, Rosenberg A, Shopsin B. et al. Preventing Surgical Site Infections: A Randomized, Open-Label Trial of Nasal Mupirocin and Nasal Povidone-Iodine at Decolonizing Staphylococcus aureus . Infect Control Hosp Epidemiol 2014; 35: 826-832
• 60 Moran C, Grussemeyer CA, Spalding JR, Benjamin DK, Reed SD. Efficacy of 5% Povidone-Iodine Nasal Solution in Eradicating Nasal Carriage of Staphylococcus aureus in Healthcare Workers. Am J Infect Control 2010; 38: 78-80
• 61 Martin RM, Patel R, Kramer MS. et al. Effect of a Chlorhexidine and Mupirocin Decolonization Strategy on Incidence of Healthcare-Associated Infections in Critically Ill Children: A Randomized Clinical Trial. JAMA. 2013; 309: 1005-1012
• 62 Sharara SL, Maragakis LL, Cosgrove SE. Decolonization of Staphylococcus aureus . Infect Dis Clin North Am 2021; 35: 107-133